Emil Kuriakose is Chief Medical Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 54,269 shares of TERN, which is worth approximately $302,278. The most recent transaction as insider was on Jan 02, 2025, when has been sold 4,481 shares (Common Stock) at a price of $5.71 per share, resulting in proceeds of $25,586. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.3K
n/a 3M change
n/a 12M change
Total Value Held $302,278

Emil Kuriakose Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
SELL
Open market or private sale
$25,586 $5.71 p/Share
4,481 Reduced 7.63%
54,269 Common Stock

Also insider at

CALA
Calithera Biosciences, Inc. Healthcare
EK

Emil Kuriakose

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on TERN

Follow Terns Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

News

Receive news related to Terns Pharmaceuticals, Inc.

Track Activities on TERN